Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | Charles River Laboratories International | 9.42 Bn | 9.21 Bn | 744.94 Mn | -54.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -54.47% |
| Sep 27, 2025 | 65.11% |
| Jun 28, 2025 | -13.13% |
| Mar 29, 2025 | 64.03% |
| Dec 28, 2024 | -27.78% |
| Sep 28, 2024 | 162.09% |
| Jun 29, 2024 | 14.84% |
| Mar 30, 2024 | -34.96% |
| Dec 30, 2023 | 137.79% |
| Sep 30, 2023 | 38.91% |
| Jul 1, 2023 | -88.17% |
| Apr 1, 2023 | -31.10% |
| Dec 31, 2022 | -24.72% |
| Sep 24, 2022 | 34.41% |
| Jun 25, 2022 | -36.66% |
| Mar 26, 2022 | 51.32% |
| Dec 25, 2021 | -34.46% |
| Sep 25, 2021 | 71.64% |
| Jun 26, 2021 | -155.48% |
| Mar 27, 2021 | 123.05% |